Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Oct 12, 2010

Premium

Gary Schroth has left his post as senior director for research development at Illumina to join WaferGen Biosystems as senior vice president of genomics research and applications, a new position in which he will help develop the company's real-time PCR technology and business.

At Illumina, he was responsible for research and development of gene expression applications for the firm's sequencing platform. Prior to that, he held various research and management roles at Applied Biosystems (now part of Life Technologies), Genelabs Technologies, and Gen-Probe. Schroth holds a PhD and a BS in biochemistry from the University of California at Davis.


Eric Schadt has been appointed to an external scientific panel for the Genotype-Tissue Expression, or GTEx, project launched last week by the National Institutes of Health. He is the chief scientific officer of Pacific Biosciences.


David Altshuler and Sydney Brenner are among 65 new members and four new foreign associates elected to the Institute of Medicine, bringing its total active membership to 1,649 and the number of foreign associates to 96. Established in 1970 by the National Academy of Sciences, the IOM is both an honorific membership organization and an advisory organization for health issues.

Altshuler is an associate professor in the departments of genetics and medicine at Harvard Medical School and an assistant molecular biologist at Massachusetts General Hospital. Brenner, a Nobel laureate, is a senior distinguished fellow of the Crick-Jacobs Center at the Salk Institute for Biological Sciences in La Jolla, Calif.


Barney Saunders has left his post as chief commercial officer at IntegenX — formerly Microchip Biotechnologies — to take up the same position at NanoString Technologies, where he will be responsible for leading the development of the firm's business. Prior to IntegenX, he was vice president and general manager at Agilent Technologies, where he led the gene expression business unit. Before that, he spent 13 years at Amersham Biosciences, where he held a variety of commercial positions in the US and overseas. He holds a PhD and a BS in biological sciences from the University of Birmingham in the UK.


Han Cao, founder and chief scientific officer of BioNanomatrix, has won the Chinese Rising Star Entrepreneur award at the China International Economic and Technical Cooperation Forum in Beijing. The award recognizes his "entrepreneurial spirit and success" in founding the company and developing its single-molecule genomic analysis technology.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.